Keyword

reimbursement decisions

Description: Reimbursement decisions are determinations by health insurers or public agencies about whether and how to pay for healthcare services, medicines, or technologies.

Primary topic: Health Systems, Economic Evaluations, Quality of Life (60%)

OpenAlex ID: keywords/coverage-decisions

Economic Evaluation in Clinical Trials

2014 · Henry A. Glick, Jalpa A. Doshi, et al. · Oxford University Press eBooks · 910

Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report

2015 · Scott D. Ramsey, Richard J. Willke, et al. · Value in Health · 809

Use of Cost-Effectiveness Analysis in Health-Care Resource Allocation Decision-Making: How Are Cost-Effectiveness Thresholds Expected to Emerge?

2004 · Hans-Georg Eichler, Sheldon X. Kong, et al. · Value in Health · 790

Health Technology Assessment (HTA)

2007 · W. Greiner · Springer eBooks · 463

A rational framework for decision making by the National Institute For Clinical Excellence (NICE)

2002 · Karl Claxton, Mark Sculpher, et al. · The Lancet · 455

Methods for Population-Adjusted Indirect Comparisons in Health Technology Appraisal

2017 · David M. Phillippo, Anthony E. Ades, et al. · Medical Decision Making · 397

PDF

Economic Evaluation in Clinical Trials

2007 · Henry A. Glick, Jalpa A. Doshi, et al. · OUP Catalogue · 366

Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting

2011 · S. Petrou, A. Gray · BMJ · 292

PDF

Assessing the Value of Healthcare Interventions Using Multi-Criteria Decision Analysis: A Review of the Literature

2014 · Kevin Marsh, Tereza Lanitis, et al. · PharmacoEconomics · 278

Ten arguments for a societal perspective in the economic evaluation of medical innovations

2009 · Bengt Jönsson · The European Journal of Health Economics · 261

PDF

Assessing the cost-effectiveness of pharmacogenomics

2000 · David L. Veenstra, Mitchell K. Higashi, et al. · AAPS PharmSci · 160

PDF

Coverage with Evidence Development, Only in Research, Risk Sharing, or Patient Access Scheme? A Framework for Coverage Decisions

2012 · Simon Walker, Mark Sculpher, et al. · Value in Health · 143

PDF

Reliability of Information Abstracted from Patients?? Medical Records

1978 · Linda K. Demlo, Paul M. Campbell, et al. · Medical Care · 135

Strengths and weaknesses of ‘real-world’ studies involving non-vitamin K antagonist oral anticoagulants

2018 · A John Camm, Keith A A Fox · Open Heart · 125

PDF

Estimating country-specific cost-effectiveness from multinational clinical trials

1998 · Richard J. Willke, Henry A. Glick, et al. · Health Economics · 125

Establishing the Cost-Effectiveness of New Pharmaceuticals under Conditions of Uncertainty—When Is There Sufficient Evidence?

2005 · Mark Sculpher, Karl Claxton · Value in Health · 121

The efficiency frontier approach to economic evaluation of health‐care interventions

2010 · J. Jaime Caro, Erik Nord, et al. · Health Economics · 119

Value in Pharmaceutical Pricing

2013 · Valérie Paris, Annalisa Belloni · OECD health working papers · 115

Adherence to treatment of osteoporosis: a need for study

2007 · F. Lekkerkerker, J. A. Kanis, et al. · Osteoporosis International · 114

Using Real-World Data in Health Technology Assessment (HTA) Practice: A Comparative Study of Five HTA Agencies

2017 · Amr Makady, Ard van Veelen, et al. · PharmacoEconomics · 112

PDF

Dangerous omissions: the consequences of ignoring decision uncertainty

2010 · Susan C. Griffin, Karl P. Claxton, et al. · Health Economics · 112

From Good to Better: New Dutch Guidelines for Economic Evaluations in Healthcare

2016 · Matthijs Versteegh, Saskia Knies, et al. · PharmacoEconomics · 109

PDF

A cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable population

2012 · Mattias Neyt, Hans Van Brabandt, et al. · BMJ Open · 109

PDF

Giving Patients’ Preferences a Voice in Medical Treatment Life Cycle: The PREFER Public–Private Project

2017 · Esther W. de Bekker-Grob, Conny Berlin, et al. · Patient · 108

PDF

The value of psychological treatment for borderline personality disorder: Systematic review and cost offset analysis of economic evaluations

2017 · Denise Meuldijk, Alexandra McCarthy, et al. · PLoS ONE · 106

PDF

Works count: 1,773

Citation count: 18,170